Dr Stephen Man
Projects as PI
- Breaking T cell tolerance in chronic lymphocytic leukaemia (01/02/2010 - 01/02/2013)
- Concept testing for the novel "cancer vaccine" (01/04/2008 - 30/09/2009)
- Defining novel targets for immunotheraphy of prostate cancer (01/07/2006 - 31/12/2009)
- REALISTIC: A phase 1, dose escalation of trial of recombinant listeria moncytogenes (lm) based vaccine encoding human papilloma virus serotype 16 target antigens (ADXS11-001) in patients with HPV-16+ oropharyngeal SCC (01/10/2010 - 30/09/2015)
- Structural and functional impact of side-chain modification of peptides recognised by CD8+ cells (01/10/2015 - 31/12/2016)
Projects as Co-Investigator
- Are prostate cancer stem cells susceptible to T cell-mediated killing? (01/10/2015 - 30/09/2018)
- CD200: A putative target of AML (01/12/2008 - 30/11/2011)
- Prostate cancer immunity during androgen deprivation and the role of hepatocyte growth factor (01/04/2006 - 30/09/2011)
- Resetting the TiME (Tumour Immune Micro-Environment) (01/06/2021 - 25/04/2025)